human C-1 esterase inhibitor (CSL)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman C-1 esterase inhibitor (CSL)
Drug Alias Namehuman C-1 esterase inhibitor (CEVEC)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement C1s inhibitors
TargetsComplement C1s
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCevec Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCevec PharmaceuticalsCsl Ltd
Active IndicationsN/A
Inactive IndicationsAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A